Phase
Condition
Diabetes Prevention
Obesity
Treatment
N/AClinical Study ID
Ages > 20 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Men and women >20 years old.
Scheduled for surgical intervention to extract adipose tissue.
Signed informed consent for study participation.
Exclusion
Exclusion Criteria:
Not meeting inclusion criteria.
Non-obesity-related systemic diseases (cancer, severe kidney/liver disease).
Systemic diseases with intrinsic inflammation (rheumatoid arthritis, Crohn'sdisease, asthma, chronic infections (HIV/tuberculosis)) or any type of infectiousdisease.
Pregnant/breastfeeding women.
Persons under legal/administrative restrictions.
Those with infection symptoms in the past month.
Use of antibiotics/antifungals/antivirals (previous 3 months).
Chronic steroidal/anti-inflammatory drug use.
Major psychiatric history.
Excessive alcohol intake, acute or chronic (>40g/day (women), >80g/day (men)) ordrug abuse.
Immunosuppressants treatment.
Participants with severe eating disorders.
Serum liver enzymes (GOT, GPT) above twice the upper limit of normal. Obvious signsor symptoms of liver disease, acute or chronic hepatitis.
History of iron balance disorders (e.g., genetic hemochromatosis, hemosiderosis fromany cause, atransferrinemia, paroxysmal nocturnal hemoglobinuria).
Creatinine greater than 1.2 and glomerular filtration rate below 40.
Current treatment for malignant neoplasia, other than basal cell or squamous cellskin cancer.
Heart disease classified as class III or IV, known ischemic cardiovascular disease.
Renal failure, history of kidney transplant, or current dialysis treatment.
Chronic constipation (bowel movement frequency ≥ 7 days) .
Study Design
Connect with a study center
Institut d'Investigació Biomèdica de Girona (IDIBGI)
Girona, 17007
SpainActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.